Rtw Investments as of March 31, 2016
Portfolio Holdings for Rtw Investments
Rtw Investments holds 34 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 19.7 | $54M | 866k | 62.77 | |
| Incyte Corporation (INCY) | 10.0 | $28M | 379k | 72.47 | |
| La Jolla Pharmaceuticl Com Par | 8.9 | $24M | 1.2M | 20.91 | |
| Achillion Pharmaceuticals | 7.2 | $20M | 2.6M | 7.72 | |
| Kite Pharma | 5.7 | $16M | 344k | 45.91 | |
| Omeros Corporation (OMER) | 5.0 | $14M | 892k | 15.34 | |
| Avexis | 4.7 | $13M | 473k | 27.24 | |
| Dicerna Pharmaceuticals | 3.9 | $11M | 2.0M | 5.36 | |
| Agenus (AGEN) | 3.6 | $10M | 2.4M | 4.16 | |
| Bluebird Bio (BLUE) | 3.5 | $9.6M | 226k | 42.50 | |
| Five Prime Therapeutics | 3.4 | $9.2M | 227k | 40.63 | |
| Mirati Therapeutics | 3.3 | $9.2M | 429k | 21.40 | |
| Symmetry Surgical | 3.3 | $9.1M | 920k | 9.86 | |
| Atara Biotherapeutics (ATRA) | 3.3 | $9.0M | 473k | 19.03 | |
| Bristol Myers Squibb (BMY) | 2.5 | $7.0M | 110k | 63.88 | |
| BioCryst Pharmaceuticals (BCRX) | 2.0 | $5.6M | 2.0M | 2.83 | |
| iShares Barclays 20+ Yr Treas.Bond (TLT) | 1.4 | $3.9M | 30k | 130.60 | |
| Celldex Therapeutics | 1.4 | $3.7M | 989k | 3.78 | |
| Corium Intl | 1.2 | $3.2M | 828k | 3.86 | |
| Global Blood Therapeutics In | 1.1 | $3.0M | 191k | 15.86 | |
| Regenxbio Inc equity us cm (RGNX) | 0.9 | $2.6M | 241k | 10.80 | |
| Lipocine | 0.9 | $2.4M | 240k | 10.15 | |
| Accelr8 Technology | 0.6 | $1.7M | 117k | 14.37 | |
| Invuity | 0.6 | $1.5M | 213k | 7.22 | |
| Cytrx | 0.5 | $1.4M | 513k | 2.68 | |
| Masimo Corporation (MASI) | 0.4 | $1.1M | 26k | 41.85 | |
| MannKind Corporation | 0.3 | $899k | 4.4k | 205.02 | |
| Biopharmx | 0.3 | $764k | 701k | 1.09 | |
| Allscripts Healthcare Solutions (MDRX) | 0.2 | $634k | 48k | 13.21 | |
| Natera (NTRA) | 0.1 | $302k | 32k | 9.53 | |
| Nivalis Therapeutics | 0.1 | $125k | 30k | 4.17 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $63k | 7.7k | 8.19 | |
| Nevro (NVRO) | 0.0 | $36k | 142.00 | 253.52 | |
| Berkshire Hathaway (BRK.B) | 0.0 | $7.0k | 50.00 | 140.00 |
